Log In
Print
BCIQ
Print
Print this Print this
 

Crixivan, indinavir sulphate (L-735524, MK-639)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionHIV protease inhibitor
Molecular Target HIV protease
Mechanism of ActionViral protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat AIDS; Treat HIV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today